Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Ding

Showing results (1261-1270 of 1,271) with videos related to

Pageof 128
Sort By:
Molecular Informatics|July 20, 2024
Exploring drug repositioning possibilities of kinase inhibitors via molecular simulationQing-Xin Wang, Jiao Cai, Zi-Jun Chen, et al.
Drug Development Research|January 16, 2023
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemiaQing-Xin Wang, Yi-Bo Wang, Jiu-Kai Sha, et al.
BMJ Open|December 3, 2025
Steerable versus Conventional flexible and navigable suction ureteral access sheath (FANS) flexible Ureteroscopy for Lower Pole stones Treatment: study protocol for a multicentre, randomised superiority trial (SCULPT trial)Steffi Kar Kei Yuen, Shusheng Liu, Vineet Gauhar, et al.
Journal of Medicinal Chemistry|September 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 MutationsTian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, et al.
Cell Metabolism|August 20, 2022
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosisYing Xi, Ryan LaCanna, Hsiao-Yen Ma, et al.
Bioorganic & Medicinal Chemistry|July 21, 2022
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemiaJi-Bo Kang, Lu Chen, Xue-Jiao Leng, et al.
Signal Transduction and Targeted Therapy|February 19, 2026
The consensus molecular subtypes of esophageal squamous cell carcinomaHeyang Cui, Zhongxu Zhu, Enwei Xu, et al.
Nature Medicine|April 24, 2019
A safe and potent anti-CD19 CAR T cell therapyZhitao Ying, Xue F Huang, Xiaoyu Xiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 24, 2023
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemiaShan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, et al.
Cell|September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapyMara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
Pageof 128

Showing results (1261-1270 of 1,271) with videos related to

Sort By:
Pageof 128
Molecular Informatics|July 20, 2024
Exploring drug repositioning possibilities of kinase inhibitors via molecular simulationQing-Xin Wang, Jiao Cai, Zi-Jun Chen, et al.
Drug Development Research|January 16, 2023
Discovery of 4-(4-aminophenyl)-6-phenylisoxazolo[3,4-b]pyridine-3-amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemiaQing-Xin Wang, Yi-Bo Wang, Jiu-Kai Sha, et al.
BMJ Open|December 3, 2025
Steerable versus Conventional flexible and navigable suction ureteral access sheath (FANS) flexible Ureteroscopy for Lower Pole stones Treatment: study protocol for a multicentre, randomised superiority trial (SCULPT trial)Steffi Kar Kei Yuen, Shusheng Liu, Vineet Gauhar, et al.
Journal of Medicinal Chemistry|September 11, 2024
Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 MutationsTian-Hua Wei, Zi-Xuan Wang, Meng-Yi Lu, et al.
Cell Metabolism|August 20, 2022
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosisYing Xi, Ryan LaCanna, Hsiao-Yen Ma, et al.
Bioorganic & Medicinal Chemistry|July 21, 2022
Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemiaJi-Bo Kang, Lu Chen, Xue-Jiao Leng, et al.
Signal Transduction and Targeted Therapy|February 19, 2026
The consensus molecular subtypes of esophageal squamous cell carcinomaHeyang Cui, Zhongxu Zhu, Enwei Xu, et al.
Nature Medicine|April 24, 2019
A safe and potent anti-CD19 CAR T cell therapyZhitao Ying, Xue F Huang, Xiaoyu Xiang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 24, 2023
Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemiaShan-Liang Sun, Jia-Zhen Wu, Jing-Jing Wang, et al.
Cell|September 27, 2014
Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapyMara H Sherman, Ruth T Yu, Dannielle D Engle, et al.
Pageof 128